GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q3II23)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q3II23) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q3II23
Type
protein
Length
418 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xE136f7458dc8cd9A7a4468E4BCD663dA9A275Ba3
Molecule
Serine hydroxymethyltransferase
UniProt
Q3II23
Pockets
3 · best druggability 0.45

Structure

1 distinct chain · 47% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41847% helix, 14% strandQ3II23

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11580.450.7624empty
21690.440.7532empty
3520.270.7416empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.